Data / Form D filings / MERRIMACK PHARMACEUTICALS INC
MERRIMACK PHARMACEUTICALS INC: Form D filing
MERRIMACK PHARMACEUTICALS INC, a pharmaceuticals company in Cambridge, MA, filed a Form D with the SEC in 2011. The latest, on April 13, 2011, reports $77 million sold of a $77 million offering to 61 investors.
Find out what MERRIMACK PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE KENDALL SQUARE, SUITE B7201, Cambridge, MA, 02139
- Phone
- (617) 441-1000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1274792
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 13, 2011 | New notice | $77,000,000 | $77,000,000 | $0 | 61 | Apr 6, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gordon A. Fehr | Director | |
| William A. Sullivan | Executive Officer | |
| Robert J. Mulroy | Executive Officer, Director | |
| Gary A. Crocker | Director | |
| Walter A. Lovenberg | Director | |
| Anthony A. Sinskey | Director | |
| Michael A. Porter | Director | |
| Sarah A. Nash | Director | |
| Robert A. Gay | Director | |
| James A. Dresser | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Apr 11, 2011 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what MERRIMACK PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.